APP and Alzheimer disease: The administration of 30 mg/kg of caffeic acid for 30 weeks was shown to ameliorate the memory of the animals, as well as affected the major biochemical targets of AD: decreased the expression of phosphorylated (p)-tau protein, attenuated APP expression, and regulated Aβ deposition [30].